Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) for the Treatment of Retinal Conditions. A Review of Clinical Studies
Yusuf Mushtaq,1,* Maryam M Mushtaq,2,* Zisis Gatzioufas,3 Matteo Ripa,4 Lorenzo Motta,5 Georgios D Panos1 1Department of Ophthalmology, Queen's Medical Centre, Nottingham University Hospitals NHS Trust & School of Medicine, University of Nottingham, Nottingham, UK; 2Departme...
Saved in:
Main Authors: | Mushtaq Y (Author), Mushtaq MM (Author), Gatzioufas Z (Author), Ripa M (Author), Motta L (Author), Panos GD (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema
by: Messenger WB, et al.
Published: (2013) -
Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies
by: Michal Pochopien, et al.
Published: (2019) -
Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant
by: Stéphanie Baillif, et al.
Published: (2022) -
Biomarkers to Predict the Success of Treatment with the Intravitreal 0.19 mg Fluocinolone Acetonide Implant in Uveitic Macular Edema
by: Lucy Joanne Kessler, et al.
Published: (2022) -
Scleral melt following Retisert intravitreal fluocinolone implant
by: Georgalas I, et al.
Published: (2014)